PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Centre for Epidemiology, Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, 28029 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, 28029 Madrid, Spain.\', \'National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Ctra de Pozuelo 28, 28222 Madrid, Spain.\', \'Departments of Epidemiology and Biostatistics, Harvard T H Chan School of Public Health, Harvard-MIT Division of Health Sciences and Technology, 677 Huntington Ave, Boston, MA 02115, USA.\', \'National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Ctra de Pozuelo 28, 28222 Madrid, Spain; Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, 28029 Madrid, Spain.\', \'Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, 28029 Madrid, Spain; National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), Ctra de Pozuelo 28, 28222 Madrid, Spain.\', \'Deputy Directorate of Information Technologies, Ministry of Health, Paseo del Prado 18, 28014 Madrid, Spain.\', \'National School of Public Health, Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, 28029 Madrid, Spain.\', \'Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, 28029 Madrid, Spain.\', \'National Centre for Epidemiology, Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, 28029 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, 28029 Madrid, Spain. Electronic address: mpollan@isciii.es.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0895-4356(21)00183-910.1016/j.jclinepi.2021.06.005
?:hasPublicationType
?:journal
  • Journal of clinical epidemiology
is ?:pmid of
?:pmid
?:pmid
  • 34126206
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.862
?:rankingScore_hIndex
  • 182
is ?:relation_isRelatedTo_publication of
?:title
  • ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all